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Associate Prof. Grace Liejun Guo is a tenured faculty in the Department of Pharmacology and Toxicology in the School of Pharmacy at the Rutgers University in New Jersey, USA.

Dr. Guo graduated from the West China University of Medical Sciences in 1993. In 1997, Dr. Guo obtained a MS degree in Immunology at the University of Arkansas for Medical Science, in 2001, a Ph.D. degree in Toxicology at the University of Kansas Medical Center, and from 2001 to 2004, the post-doctoral training at the NCI, NIH. Dr. Guo has been a tenured faculty at the Department of Pharmacology, Toxicology and Therapeutics at the University of Kansas Medical Center (2004--2012), and a tenured faculty at the Rutgers University (2012--present).

For the last two decades, Dr. Guo has determined the roles of nuclear receptors and signaling pathways that are critical for liver homeostasis and metabolism, including farnesoid X receptor (FXR), pregnane X receptor, constitutive androstane receptor, fibroblast growth factor 15/19 and bile acids. The highlights of Dr. Guo׳s research findings include understanding the cellular and molecular mechanism by which tissue-specific FXR functions to regulate bile acid homeostasis, transcriptional regulation of drug metabolism and transport, non-alcoholic hepatosteatosis, liver and colon carcinogenesis, and liver regeneration.

Dr. Guo has published over 75 peer-reviewed research and review articles on nuclear receptors and their regulation of liver and intestine functions. As the PI or Co-I on several NIH funding, Dr. Guo׳s laboratory has laid the ground work by determining the role of intestinal FXR in regulating liver functions.

Dr. Guo is a member of several scientific societies, scientific reviewer for the US and Italian NIH and private foundations, editorial board member and ad hoc manuscript reviewers for numerous prestigious journals, and invited speakers for national and international lectures and meetings.
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Dr. Huiping Zhou received the BS and MS degrees from China Pharmaceutical University, Nanjing, China and a Ph.D. from University of Kentucky, Lexington, Kentucky, USA. After one year of postdoctoral training at the College of Pharmacy, University of Kentucky, Dr. Zhou was recruited to the Medical College of Virginia, Virginia Commonwealth University as a Senior Research Scientist in the Department of Internal Medicine/Gastroenterology Division. Currently, Dr. Zhou is a tenured Associate Professor in the Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA.

Dr. Zhou has more than 20 years׳ research experience in pharmacology and molecular biology. Her current research focuses on studying ER stress and inflammation in metabolic diseases and drug-induced liver injury. For the past 10 years Dr. Zhou׳s laboratory has been investigating the cellular and molecular mechanisms of HIV protease inhibitor-induced dyslipidemia and atherosclerosis by using *in vitro* cell culture systems and *in vivo* animal models. Her lab first identified that the unfolded protein response (UPR) plays an important role in HIV PI-induced inflammation and dysregulation of lipid metabolism in macrophages and hepatocytes. Recently, her lab first identified that the conjugated bile acid\--induced activation of sphingosine-1-phopsphate receptor 2 plays an important role in regulating hepatic lipid metabolism and cholangiocyte proliferation.

Dr. Zhou has published over 100 SCI peer-reviewed articles and reviews in prestigious journals such as *Hepatology, Cell Metabolism, Gastroenterology, Journal of Lipid Research, Molecular Pharmaceutics, Journal of Biological Chemistry, Journal of Molecular and Cellular Cardiology, Journal of Cellular and Molecular Medicine and PLoS One*. Her research has been continuously funded by the National Institute of Health (NIH), Veterans Merit Award, National Science Foundation of China and pharmaceutical companies. Dr. Zhou is an internationally well-known expert in the field of ER stress, hepatic lipid metabolism and bile acid signaling. She is a current member of the VA Merit Award Gastroenterology Study Section. She reviewed grant applications for several NIH study sections, the Natural Science Foundation of China and several other private funding agencies. In addition, she serves as an Editorial Board member for several prestigious journals and ad hoc reviewer for more than 50 top-notch journals. She was invited to present her research at many international meetings, universities and institutes. During the last eight years, Dr. Zhou has trained many Ph.D. students and postdoctoral fellows including visiting students from China. Most of them are currently holding faculty positions in universities.
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